Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06270901
Other study ID # BMEL: 2822EPS008
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date July 30, 2024

Study information

Verified date April 2024
Source University of Bonn
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to investigate the postprandial effects of legume-enriched meals compared to Western Diet meals on postprandial metabolism. In this context, older adults with increased risk for cardiometabolic diseases consume 4 mixed meals with 36 g or 62 g of protein either designed according to the Planetary Health Diet with legumes as primary protein source or the Western Diet with animal foods as primary protein source, in a randomized order. In a postprandial observation period of 6 hours, parameters of lipid metabolism, glucose and insulin metabolism, amino acid profile, as well as markers of inflammation and vascular function are analysed. Furthermore, neuropsychological parameters and satiety-associated hormones are investigated.


Description:

In a randomized crossover design, 30 older men and women with increased risk for cardiometabolic diseases consume 4 mixed meals, which differ in dietary pattern, protein source and protein quantity. Two meals are designed according to the Planetary Health Diet with legumes as primary protein source whereas the other two meals are designed according to the Western Diet with animal food as primary protein source. Two meals are designed as high protein meals (62 g of protein) and two meals are designed as low protein meals (36 g of Protein). Therefore, participants consume 4 different test meals, a Low and a High Protein Western Diet Meal and a Low and a High Protein Planetary Health Diet Meal in a randomized order. During a postprandial observation period of 6 hours, parameters of lipid metabolism (e.g., plasma triglycerides), glucose metabolism (e.g., plasma glucose, serum insulin), as well as markers of inflammation (e.g., IL-6) and vascular function (e.g., pulse wave velocity) are analysed. Furthermore, amino acid profile, neuropsychologic parameters (e.g., appetite) and satiety-associated hormones (e.g., Ghrelin) are investigated. Each intervention will be separated by a washout period of approximately 14 days.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 30, 2024
Est. primary completion date July 30, 2024
Accepts healthy volunteers No
Gender All
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria: - written informed consent - Non-smoking - BMI: 27 - 34,9 kg/m2 - Waist circumference (women = 80 cm, men = 94 cm) - Systolic blood pressure: = 120 mmHg, diastolic blood pressure: = 80 mmHg - At least one of the following criteria - Fasting triglycerides in serum: = 150 mg/dL - Fasting HDL-Cholesterol in serum: women < 50 mg/dl, men < 40 mg/dL - Fasting C-reactive protein in serum: = 2 mg/L - Fasting glucose in plasma: = 100 mg/dL Exclusion Criteria: - food intolerances and allergies (especially to legumes) - Smoking - malabsorption syndromes - thyroid diseases - impaired renal function - chronic liver disease - heart failure - myocardial infarction - insulin-dependent diabetes mellitus - chronic inflammatory diseases - tumors - anemia - immunosuppression - intake of supplements (e.g., fish oil) - Participation in another study - other exclusion criteria at the discretion of the physician/ investigator

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High Protein Planetary Health Diet
Planetary Health Diet Meal with 62 g of protein primarily from plant origin
Low Protein Planetary Health Diet
Planetary Health Diet Meal with 36 g of protein primarily from plant origin
High Protein Western Diet
Western Diet Meal with 62 g of protein primarily from animal origin
Low Protein Western Diet
Western Diet Meal with 36 g of protein primarily from animal origin

Locations

Country Name City State
Germany University of Bonn, Institute of Nutritional and Food Sciences, Nutrition Physiology Bonn North-Rhine Westphalia

Sponsors (3)

Lead Sponsor Collaborator
University of Bonn Federal Ministry of Food and Agriculture (BMEL), Federal Office for Agriculture and Food (BLE)

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Parameters of lipid metabolism in blood Triglycerides (mg/dL) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of lipid metabolism in blood Total cholesterol (mg/dL) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of lipid metabolism in blood LDL cholesterol (mg/dL) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of lipid metabolism in blood HDL cholesterol (mg/dL) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of lipid metabolism in blood Free fatty acids (mmol/L) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of glucose metabolism in blood Glucose (mg/dL) Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Secondary Parameters of glucose metabolism in blood Insulin (nmol/L) Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Secondary Parameters of glucose metabolism in blood cPeptide (pg/mL) Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 6 hours)
Secondary Parameters of glucose metabolism in blood GLP-1 (pg/mL) Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of glucose metabolism in blood Glucagon (pg/mL) Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Secondary Blood amino acid profile Amino acid profile in blood (nmol/mL) Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Secondary Blood urea Urea in blood (mg/dL) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Uric acid in blood Uric acid in blood (mg/dL) Postprandial period of 6 hours (T=0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of hunger and satiety in blood e.g. Ghrelin (pg/mL) Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of endothelial function in blood e.g. ADMA (µmo/L) Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Secondary Parameters of inflammation in blood e.g. IL-6 (pg/mL) Postprandial period of 6 hours (T= 0, 1, 2, 3, 4, 6 hours)
Secondary Endothelial function e.g. pulse wave velocity (m/s) Postprandial period of 6 hours (T=0, 2, 4, 6 hours)
Secondary Neuropsychological parameters Assessment of hunger and satiety via a visual analogue scale (e.g. 0 = not hungry at all to 10 = very hungry) Postprandial period of 6 hours (T=0, 0.5, 1, 1.5, 2, 3, 4, 5, 6 hours)
Secondary Neuropsychological parameters Assessment of attention via questionnaire (paper pencil test, e.g. higher amount of marked target items = higher attention, maximum points 640 = every target items marked correctly, minimum points: 0 = no target items marked or only wrong items marked) Postprandial period of 4.5 hours (T= 0, 1.5, 3, 4.5 hours)
Secondary Neuropsychological parameters Assessment of memory via questionnaire (paper pencil, e.g. higher reproduction of memorised visual and verbal information = better memory; visual part: maximum points: 31 = all visual information memorised, minimum points: 0 = no visual information memorised; verbal part: maximum points: 24 = all verbal information memorised, minimum points: 0 = no verbal information memorised) Postprandial period of 6 hours (T=0.5, 3, 6 hours)
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04098172 - Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR N/A